To be or not to B27 positive: implications for the phenotypes of axial spondyloarthritis outcomes. Data from a large multiracial cohort from the Brazilian Registry of Spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/38671475/

Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering (2024)
https://pubmed.ncbi.nlm.nih.gov/38801195/

HLA-B27 positivity in a large miscegenated population of 5,389,143 healthy blood marrow donors in Brazil (2023)
https://pubmed.ncbi.nlm.nih.gov/37081582/

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries (2023)
https://pubmed.ncbi.nlm.nih.gov/36787993/

Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study (2022)
https://pubmed.ncbi.nlm.nih.gov/34901885/

Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients (2022)
https://pubmed.ncbi.nlm.nih.gov/35142560/

Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases (2022)
https://pubmed.ncbi.nlm.nih.gov/35277389/

Interaction of TNFi and conventional synthetic DMARD in SARS-COV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/36150668/

Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients (2022)
https://pubmed.ncbi.nlm.nih.gov/36192386/

Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33468245/

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial (2021)
https://pubmed.ncbi.nlm.nih.gov/34331051/

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34819174/

Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors (2020)
https://pubmed.ncbi.nlm.nih.gov/31942038/

The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019 (2020)
https://pubmed.ncbi.nlm.nih.gov/32171329/

Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area (2020)
https://pubmed.ncbi.nlm.nih.gov/33206754/

Assessing bone impairment in ankylosing spondylitis (AS) using the trabecular bone score (TBS) and high-resolution peripheral quantitative computed tomography (HR-pQCT) (2019)
https://pubmed.ncbi.nlm.nih.gov/30708186/

Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors (2018)
https://pubmed.ncbi.nlm.nih.gov/30657103/

Monocytes from male patients with ankylosing spondylitis display decreased osteoclastogenesis and decreased RANKL/OPG ratio (2018)
https://pubmed.ncbi.nlm.nih.gov/30006885/